Ocugen (NASDAQ:OCGN) Shares Gap Down to $0.56

Share on StockTwits

Ocugen (NASDAQ:OCGN) gapped down prior to trading on Tuesday . The stock had previously closed at $0.58, but opened at $0.56. Ocugen shares last traded at $0.41, with a volume of 5,873,600 shares traded.

Separately, ValuEngine upgraded shares of Ocugen from a “hold” rating to a “buy” rating in a report on Friday, November 1st.

The firm has a market capitalization of $8.95 million, a P/E ratio of -0.01 and a beta of 2.92.

In other Ocugen news, Director Howard C. Draft acquired 68,965 shares of the stock in a transaction dated Thursday, September 26th. The shares were purchased at an average price of $29.00 per share, for a total transaction of $1,999,985.00. Also, Director Junge Zhang acquired 31,078 shares of the stock in a transaction dated Monday, September 30th. The stock was acquired at an average price of $3.09 per share, for a total transaction of $96,031.02. Insiders bought a total of 209,043 shares of company stock worth $2,153,696 in the last quarter. Company insiders own 44.70% of the company’s stock.

Ocugen Company Profile (NASDAQ:OCGN)

Ocugen, Inc, a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases.

Featured Story: What is Depreciation?

Receive News & Ratings for Ocugen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ocugen and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  Sees Large Volume Increase
Armada Hoffler Properties Sees Large Volume Increase
Caleres  Downgraded to “Sell” at Zacks Investment Research
Caleres Downgraded to “Sell” at Zacks Investment Research
Robert W. Baird Begins Coverage on Middlesex Water
Robert W. Baird Begins Coverage on Middlesex Water
Viveve Medical  Upgraded to Buy at LADENBURG THALM/SH SH
Viveve Medical Upgraded to Buy at LADENBURG THALM/SH SH
Meta Financial Group Inc.  Plans Quarterly Dividend of $0.05
Meta Financial Group Inc. Plans Quarterly Dividend of $0.05
Eagle Materials, Inc. Announces Dividend of $0.10
Eagle Materials, Inc. Announces Dividend of $0.10


© 2006-2019 Ticker Report